.
  • NIFTY 25,713.00 +141.75 (+0.55%)
  • SENSEX 83,294.66 +479.95 (+0.58%)
BSE
NSE

Monday, February 23, 2026 , BSE Sensex : 83,294.66 83,294.66(0.58%) , Adani Ports : 1,556.55 1,556.55(2.98%) , Asian Paints : 2,428.75 2,428.75(0.02%) , Axis Bank : 1,386.55 1,386.55(1.34%) , Bajaj Finance : 1,031.05 1,031.05(0.18%) , Bajaj Finserv : 2,051.05 2,051.05(-0.34%) , Bharat Electron : 439.70 439.70(-0.33%) , Bharti Airtel : 1,997.15 1,997.15(0.98%) , Eternal : 268.10 268.10(-0.32%) , HCL Technologies : 1,426.35 1,426.35(-0.74%) , HDFC Bank : 923.85 923.85(1.31%) , Hind. Unilever : 2,344.85 2,344.85(1.29%) , ICICI Bank : 1,399.10 1,399.10(0.40%) , Infosys : 1,328.45 1,328.45(-1.80%) , Interglobe Aviat : 4,861.25 4,861.25(0.15%) , ITC : 325.35 325.35(-0.50%) , Kotak Mah. Bank : 430.70 430.70(2.22%) , Larsen & Toubro : 4,417.15 4,417.15(0.84%) , M & M : 3,445.00 3,445.00(0.94%) , Maruti Suzuki : 15,067.70 15,067.70(0.53%) , NTPC : 375.45 375.45(0.64%) , Power Grid Corpn : 303.35 303.35(1.49%) , Reliance Industries : 1,427.90 1,427.90(0.55%) , SBI : 1,227.80 1,227.80(0.96%) , Sun Pharma.Inds. : 1,732.20 1,732.20(0.45%) , Tata Steel : 208.05 208.05(-0.10%) , TCS : 2,675.85 2,675.85(-0.40%) , Tech Mahindra : 1,441.75 1,441.75(-1.06%) , Titan Company : 4,272.35 4,272.35(0.87%) , Trent : 4,053.40 4,053.40(-0.86%) , UltraTech Cem. : 12,974.50 12,974.50(1.65%) ,

Nifty 50 : 25,713.00 141.75(0.55%) , Adani Enterp. : 2,191.00 30.20(1.40%) , Adani Ports : 1,555.80 44.30(2.93%) , Apollo Hospitals : 7,693.00 77.50(1.02%) , Asian Paints : 2,429.70 1.60(0.07%) , Axis Bank : 1,386.70 18.40(1.34%) , Bajaj Auto : 9,905.50 98.50(1.00%) , Bajaj Finance : 1,031.00 0.80(0.08%) , Bajaj Finserv : 2,051.60 -6.90(-0.34%) , Bharat Electron : 439.75 -1.40(-0.32%) , Bharti Airtel : 1,997.30 19.90(1.01%) , Cipla : 1,326.50 -14.60(-1.09%) , Coal India : 426.00 2.45(0.58%) , Dr Reddy's Labs : 1,307.40 27.00(2.11%) , Eicher Motors : 8,038.50 102.00(1.29%) , Eternal : 268.00 -1.45(-0.54%) , Grasim Inds : 2,873.40 40.60(1.43%) , HCL Technologies : 1,426.20 -10.30(-0.72%) , HDFC Bank : 923.60 11.75(1.29%) , HDFC Life Insur. : 742.45 13.80(1.89%) , Hind. Unilever : 2,345.40 30.90(1.34%) , Hindalco Inds. : 916.20 -19.50(-2.08%) , ICICI Bank : 1,399.40 4.90(0.35%) , Infosys : 1,327.50 -25.70(-1.90%) , Interglobe Aviat : 4,862.20 7.60(0.16%) , ITC : 325.40 -1.60(-0.49%) , Jio Financial : 257.80 -0.80(-0.31%) , JSW Steel : 1,240.50 4.70(0.38%) , Kotak Mah. Bank : 430.70 9.35(2.22%) , Larsen & Toubro : 4,418.10 37.50(0.86%) , M & M : 3,447.10 34.30(1.01%) , Maruti Suzuki : 15,072.00 95.00(0.63%) , Max Healthcare : 1,083.60 -4.30(-0.40%) , Nestle India : 1,315.10 21.30(1.65%) , NTPC : 375.45 2.50(0.67%) , O N G C : 275.65 -3.00(-1.08%) , Power Grid Corpn : 303.35 4.40(1.47%) , Reliance Industries : 1,428.00 8.60(0.61%) , SBI : 1,227.80 11.70(0.96%) , SBI Life Insuran : 2,109.60 29.60(1.42%) , Shriram Finance : 1,064.70 5.40(0.51%) , Sun Pharma.Inds. : 1,732.30 7.90(0.46%) , Tata Consumer : 1,171.80 15.60(1.35%) , Tata Motors PVeh : 379.95 1.95(0.52%) , Tata Steel : 208.14 -0.22(-0.11%) , TCS : 2,676.30 -9.90(-0.37%) , Tech Mahindra : 1,440.90 -16.00(-1.10%) , Titan Company : 4,272.70 36.30(0.86%) , Trent : 4,054.90 -36.10(-0.88%) , UltraTech Cem. : 12,976.00 210.00(1.64%) , Wipro : 205.89 -3.97(-1.89%) , Monday, February 23, 2026

Home >> Markets >> Equities >> News - News Details
Corporate News
23-Feb-2026     19:22
Lupin receives European Commission approval for Biosimilar Ranibizumab

Lupin has received the approval from European Commission for its biosimilar ranibizumab, RanluspecTM (for vials and pre-filled syringes), following the recent positive opinion from the Committee for Medicinal Products for Human Use.

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A. Its indications encompass the treatment of patients with neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, proliferative diabetic retinopathy, and choroidal neovascularization.

Lupin's biosimilar ranibizumab will be commercialized by Sandoz across the European Union (excluding Germany). In France, the product will be commercialized by two companies, Sandoz and Biogaran.

Powered by Capital Market - Live News